Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07266818
PHASE1
A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)
Sponsor: Merck Sharp & Dohme LLC
View on ClinicalTrials.gov
Summary
The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.
Official title: A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Effect of MK-1167 on QTc in Healthy Adult Participants
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-12-18
Completion Date
2026-03-11
Last Updated
2026-02-13
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
MK-1167
Oral capsule administered once daily
DRUG
Placebo
Oral capsule administered once daily
Locations (1)
Hassman Research Institute Marlton Site ( Site 0001)
Marlton, New Jersey, United States